News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Salter Malcolm
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/16/2023 |
4
| Salter Malcolm (Director) has filed a Form 4 on C4 Therapeutics, Inc.|
Txns:
| Granted 26,000 options to buy
@ $3.61, valued at
$93.9k
|
|
| 06/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/18/2022 |
4
| Salter Malcolm (Director) has filed a Form 4 on C4 Therapeutics, Inc.|
Txns:
| Granted 428 shares
@ $31.58, valued at
$13.5k
|
|
| 12/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/19/2021 |
4
| Salter Malcolm (Director) has filed a Form 4 on C4 Therapeutics, Inc.|
Txns:
| Sold 755 shares
@ $40.11, valued at
$30.3k
|
|
| 10/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/24/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/19/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/07/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/24/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/06/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/06/2020 |
4
| Salter Malcolm (Director) has filed a Form 4 on C4 Therapeutics, Inc.|
Txns:
| Converted 11,856 shares
@ $0
Converted 2,823 shares
@ $0
Bought 1,315 shares
@ $19, valued at
$25k
Converted 100,000 preferred shares
@ $0
Converted 23,809 preferred shares
@ $0 |
|
| 10/05/2020 |
4
| Salter Malcolm (Director) has filed a Form 4 on C4 Therapeutics, Inc.|
Txns:
| Granted 17,786 options to buy
@ $19, valued at
$337.9k
|
|
|
|